HFS
REGN icon

Hughes Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Hughes Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.48K Buy
12
+3
+33% +$2.04K ﹤0.01% 421
2026
Q1 		$6.95K Buy
9
+3
+50% +$2.3K ﹤0.01% 376
2025
Q4 		$4.63K Hold
6
– – ﹤0.01% 408
2025
Q3 		$3.93K Buy
6
+5
+500% +$2.83K ﹤0.01% 425
2025
Q2 		$555 Sell
1
-3
-75% -$1.67K ﹤0.01% 905
2025
Q1 		$2.47K Buy
+4
New +$2.75K ﹤0.01% 535

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hughes Financial Services's REGN Position: Q2 2026 in Review

Hughes Financial Services increased its Regeneron Pharmaceuticals (REGN) stake by 33% in Q2 2026, buying an estimated $2.04K and bringing the position to 12 shares worth $7.48K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

Hughes Financial Services first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hughes Financial Services held 12 shares of Regeneron Pharmaceuticals worth $7.48K as of Q2 2026.
  • Hughes Financial Services bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #421 holding.
  • Hughes Financial Services first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.